Skip to main content
Premium Trial:

Request an Annual Quote

Enigma Diagnostics Licenses Rights to ABI's '907 Real-Time PCR Patent

NEW YORK (GenomeWeb News) – UK molecular diagnostics company Enigma Diagnostics said today that it has licensed access to an Applied Biosystems patent for real-time detection of nucleic acid amplification products.
 
The Porton Down, UK-based company, which specializes in decentralized and point-of-care diagnostics, said it has licensed access to US Patent No. 5,928,907, “System for real time detection of nucleic acid amplification products.”
 
Enigma said that it is the third license agreement it has signed with ABI and that the technology complements its license under other patents owned by Applied Biosystems for real-time PCR thermal cyclers.
 
Enigma also said that this is the first license ABI has granted to the methods claimed under the ‘907 patent.
 
Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more